Professor Philip Hogg on Nine News

Professor Philip Hogg, Head, ACRF Centenary Cancer Research Centre, has featured on Nine News explaining his new theranostics research, recently funded by the Cancer Institute NSW.

A form of personalised cancer treatment for the patient, the term ‘theranostics’ refers to a combined therapy and diagnostics approach where tumour markers are employed to deliver a therapeutic isotope to the tumour.

“The theranostic that we’ve developed should target all types of tumours, not just specific ones. It’s also designed so that it becomes substantially more effective with each administration rather than less effective,” said Professor Hogg.

The news story can be accessed online via the Nine Network’s website. Further information on the ACRF Centenary Cancer Research Centre can also be found online.